Tag: pharmaceutical competition

Patent Litigation: How Authorized Generics Undermine Generic Competition

Patent Litigation: How Authorized Generics Undermine Generic Competition

| 13:10 PM

Authorized generics let brand drugmakers launch their own versions during the first generic's exclusivity period, slashing revenues and discouraging patent challenges. Here's how this legal loophole hurts competition and patients.

read more